Celcuity (CELC) Appoints Polly Murphy to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Celcuity (CELC) Appoints Polly Murphy to its Board

Celcuity Appoints Polly Murphy, D.V.M., Ph.D., to Board of Directors

September 14, 2022 9:02 AM EDT

Seasoned executive brings over two decades of pharmaceutical business development and commercial strategy experience to Celcuity's Board of Directors

MINNEAPOLIS, MN / ACCESSWIRE / September 14, 2022 / Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company focused on development of targeted therapies for a number of different cancers, today announced the appointment of Polly Murphy, D.V.M., Ph.D. to its Board of Directors.

"We are delighted to welcome Dr. Murphy to our Board and look forward to leveraging her business development expertise and broad industry experience as we... More